myeloproliferative disorders

Showing 26 - 50 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Acute Myelocytic Leukemia Trial run by the NHLBI (Isolex 300i Stem Cell

Completed
  • Acute Lymphocytic Leukemia
  • +4 more
  • Isolex 300i Stem Cell Selection
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 25, 2018

Acute Leukemia, MDS, Myeloproliferative Disorders Trial in Marseille (Blood sampling, Bone marrow aspirate, Skin biopsy)

Recruiting
  • Acute Leukemia
  • +2 more
  • Blood sampling
  • +3 more
  • Marseille, France
    Institut Paoli-Calmettes
Jul 24, 2018

Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine

Unknown status
  • Myeloproliferative Disorders
    • Nice, France
      CHU de Nice
    Jul 23, 2018

    Myeloproliferative Disorders, Leukemia, Lymphoma Trial (umbilical cord blood transplantation)

    Terminated
    • Myeloproliferative Disorders
    • +3 more
    • umbilical cord blood transplantation
    • (no location specified)
    Dec 3, 2017

    Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Minneapolis (Leuprolide, hematopoietic cell transplant, reduced

    Terminated
    • Multiple Myeloma
    • +4 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Dec 3, 2017

    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic

    Completed
    • Leukemia
    • +2 more
    • Allogeneic bone marrow transplantation
    • Peripheral blood stem cell transplantation
    • Birmingham, Alabama
    • +44 more
    Oct 24, 2017

    MDS, Myeloproliferative Disorders, Leukemia, Lymphocytic Trial in Tampa (Busulfan, Fludarabine)

    Completed
    • Myelodysplastic Syndromes
    • +4 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 20, 2017

    Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Houston (drug, radiation, biological, procedure)

    Terminated
    • Leukemia
    • +3 more
    • ARA C
    • +5 more
    • Houston, Texas
      Texas Children's Hospital
    Mar 24, 2016

    Patients With Myeloproliferative Disorders

    Withdrawn
    • Myeloproliferative Disorders
    • +4 more
      • Jinan, Shandong, China
        Qilu Hospital, Shandong University
      Apr 18, 2016

      Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Chronic Myelogenous Leukemia (CML) Trial

      Completed
      • Acute Myeloid Leukemia in Remission
      • +7 more
      • Kansas City, Kansas
      • +1 more
      Feb 25, 2016

      B-Receptor Signaling in Cardiomyopathy

      Completed
      • Carcinomas
      • +37 more
        • Stanford, California
          Stanford University School of Medicine
        Nov 16, 2015

        Patients With Chronic Myeloproliferative Diseases

        Completed
        • Myeloproliferative Disorders
        • Pulmonary Hypertension
        • Echocardiography, spiroergometry, cardiac catheterization
        • Graz, Austria
          Medical University of Graz, Pulmonology
        Sep 7, 2015

        Myeloproliferative Disorders, Blood Cancer, MDS Trial in Stanford (Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as

        Completed
        • Myeloproliferative Disorders
        • +2 more
        • Total Lymphoid Irradiation (TLI)
        • Anti-Thymocyte Globulin as Conditioning (ATG)
        • Stanford, California
          Stanford University School of Medicine
        Mar 16, 2015

        AML, CML, MDS Trial in Boston, New York, San Antonio (STA-9090 (ganetespib))

        Completed
        • AML
        • +3 more
        • STA-9090 (ganetespib)
        • Boston, Massachusetts
        • +2 more
        Sep 17, 2014

        Investigation of the Cylex® ImmuKnow® Assay

        Completed
        • Leukemia
        • +8 more
          • Indianapolis, Indiana
            Indiana Universtiy Simon Cancer Center
          Sep 10, 2014

          Preleukemia, Myeloproliferative Disorders, Lymphoma Trial in Chicago (Fludarabine, Melphalan, Campath)

          Terminated
          • Preleukemia
          • +4 more
          • Chicago, Illinois
            The Uniiversity of Chicago
          Mar 14, 2014

          Myeloproliferative Disorders Trial in Houston (SB939)

          Completed
          • Myeloproliferative Disorders
          • Houston, Texas
            UT MD Anderson Cancer Center
          Dec 13, 2013

          Unrelated Stem Cell Transplantation for Hematopoietic Disorders

          Completed
          • CML
          • +5 more
            • San Francisco, California
              University of California San Francisco
            Aug 1, 2013

            Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloproliferative Disorders Trial in Houston (Hum-195/rGel)

            Completed
            • Acute Myeloid Leukemia
            • +3 more
            • Houston, Texas
              UT MD Anderson Cancer Center
            Apr 1, 2013

            Myeloproliferative Disorders, Leukemia, Lymphoma Trial (aprepitant, ondansetron HCl)

            Withdrawn
            • Myeloproliferative Disorders
            • +7 more
            • (no location specified)
            Mar 29, 2013